Autologous fat transplants to deliver glitazone and adiponectin for vasculoprotection.

about

Autologous fat transplants to deliver glitazone and adiponectin for vasculoprotection.

Item

http://www.wikidata.org/entity/Q47779172

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Autologous fat transplants to deliver glitazone and adiponectin for vasculoprotection.

@en

Autologous fat transplants to deliver glitazone and adiponectin for vasculoprotection.

@nl

type

Item

label

Autologous fat transplants to deliver glitazone and adiponectin for vasculoprotection.

@en

Autologous fat transplants to deliver glitazone and adiponectin for vasculoprotection.

@nl

prefLabel

Autologous fat transplants to deliver glitazone and adiponectin for vasculoprotection.

@en

Autologous fat transplants to deliver glitazone and adiponectin for vasculoprotection.

@nl

P1476

Autologous fat transplants to deliver glitazone and adiponectin for vasculoprotection.

@en

P2093

Alfred K Cheung

http://www.w3.org/2001/XMLSchema#string

Christi M Terry

http://www.w3.org/2001/XMLSchema#string

Huan Li

http://www.w3.org/2001/XMLSchema#string

Ilya Zhuplatov

http://www.w3.org/2001/XMLSchema#string

Jayant Agarwal

http://www.w3.org/2001/XMLSchema#string

Seong-Eun Kim

http://www.w3.org/2001/XMLSchema#string

William G Sanders

http://www.w3.org/2001/XMLSchema#string

Yuxia He

http://www.w3.org/2001/XMLSchema#string

P2860

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor

Neointimal hyperplasia associated with synthetic hemodialysis grafts.

In vivo evaluation of the delivery and efficacy of a sirolimus-laden polymer gel for inhibition of hyperplasia in a porcine model of arteriovenous hemodialysis graft stenosis.

Simultaneous determination of pioglitazone and its two active metabolites in human plasma by LC-MS/MS.

Simultaneous determination of glipizide and rosiglitazone unbound drug concentrations in plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry.

Chemical proteomics-based analysis of off-target binding profiles for rosiglitazone and pioglitazone: clues for assessing potential for cardiotoxicity.

Correlation of tissue drug concentrations with in vivo magnetic resonance images of polymer drug depot around arteriovenous graft

Vascular smooth muscle cell peroxisome proliferator-activated receptor-γ mediates pioglitazone-reduced vascular lesion formation

Assessment of Novel Anti-thrombotic Fusion Proteins for Inhibition of Stenosis in a Porcine Model of Arteriovenous Graft.

P304

237-246

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCONREL.2017.08.036

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

264

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28867378

http://www.w3.org/2001/XMLSchema#string

P932

5632591

http://www.w3.org/2001/XMLSchema#string